Micronesia, Federated States of vs Tonga: Hepatitis B surface antigen (HBsAg) prevalence
Micronesia, Federated States of
0.6%
in 2024
Tonga
0.6%
in 2024
Micronesia, Federated States of rank
51st
Tonga rank
51st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Micronesia, Federated States of
- Tonga
How they compare
Micronesia, Federated States of currently reports 0.6% against 0.6% in Tonga, a difference of 0.0%.
Across all 10 years both countries report, Tonga has been ahead every year.
Micronesia, Federated States of ranks 51st and Tonga ranks 51st of 194 countries.
Tonga has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Micronesia, Federated States of | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.1% | 0.1% | Tonga |
| 2020s | 0.6% | 0.7% | 0.1% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Micronesia, Federated States of or Tonga?
- Micronesia, Federated States of, at 0.6% against 0.6% in Tonga as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Micronesia, Federated States of and Tonga?
- 0.0%, with Micronesia, Federated States of ahead.
- How many years of comparable data are there for Micronesia, Federated States of and Tonga?
- 10 years are reported by both, from 2015 to 2024.
- How do Micronesia, Federated States of and Tonga rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Micronesia, Federated States of ranks 51st and Tonga ranks 51st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.